Harrow · 1 month ago
Manager of Financial Planning and Analysis
Harrow is a leading North American ophthalmic-focused pharmaceutical company, and they are seeking a Manager of Financial Planning and Analysis to enhance their financial reporting and analysis capabilities. This role involves overseeing budgeting processes, forecasting revenue, and developing financial models to support decision-making across the organization.
BiotechnologyHealth CareMedical
Responsibilities
Manage and oversee the annual budgeting and quarterly reforecasting process and reporting
Work with commercial analytics, operations and revenue accountant to forecast projected revenue for all product lines
Build out and maintain long-range detailed financial models (e.g. 5 years), using realizable and data driven assumptions
Lead the internal monthly financial reporting process, including drafting financial performance summary of business, budget to actual variance analysis and management reporting
Collaborate with cross-functional teams and department heads on a monthly basis to discuss budget to actual variances, reforecasts and trends and ensure alignment of financial plans with strategic objectives
Develop and maintain complex financial models to support decision-making across the organization
Analyze financial data to identify trends, risks, and opportunities for growth
Drive improvements in financial processes, systems, and reporting capabilities to enhance efficiency and accuracy
Assist in the development of quarterly/annual financial statements included in the company’s SEC filings on Form 10-Q and 10-K
Qualification
Required
Bachelor's degree in Finance, Accounting, or a related field
5+ years of relevant financial analysis experience
Possess a strong grasp of GAAP
Ability to demonstrate strong financial modeling and analytical skills
Proficiency in Microsoft Excel and financial software applications, such as Oracle PBCS
Excellent communication, presentation, and interpersonal skills
Strong attention to detail, problem-solving abilities, and a results-driven mindset
Preferred
MBA, CPA or advanced degree is a plus
Company
Harrow
Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market.
Funding
Current Stage
Public CompanyTotal Funding
$533.75MKey Investors
Oaktree Capital ManagementSWK Funding
2025-09-08Post Ipo Debt· $250M
2023-07-19Post Ipo Equity· $60M
2023-03-28Post Ipo Debt· $100M
Leadership Team
Recent News
2025-02-12
2025-02-12
Company data provided by crunchbase